Q4 2024 Management View CEO Svein Tore Holsether highlighted the company's strong operational performance in Q4 2024, achieving record-high production levels and a $90 million reduction in fixed costs ...

As the S&P 500 inches toward a record high and investors digest a flurry of earnings reports, the spotlight on smaller market players has intensified. Penny stocks, while often considered relics of ...

Investment firm Bain Capital said on Friday that it has signed an agreement to acquire Mitsubishi Tanabe Pharma from Mitsubishi Chemical Group (OTCPK:MTLHY) for approximately 510 billion JPY (3.3 ...